Paid Clinical Trials in Utah

Utah has 1,311 paid clinical trials enrolling now across cities including Salt Lake City, Murray and West Valley City. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 17, 2026.

Filter results

State

City

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

1,311 clinical trials

↓ Download CSV

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

for GEP-NET

32 locations incl. Phoenix

Sponsor: RayzeBio, Inc.

Sex: All·Age: 18+

Code: NCT05477576·Phase 3·Recruiting

Apply to this trial

Long-Term Follow-up Study

for Lymphoma, Non-Hodgkin

31 locations incl. Birmingham

Sponsor: Caribou Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT05332054·Enrolling By Invitation

Dual Implant Versus Single Implant Distal End of Femur

for Distal Femur Fracture

5 locations incl. Rochester

Sponsor: University of Utah

Sex: All·Age: 60 - 100

Code: NCT05292313·Enrolling By Invitation

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

for B-cell Acute Lymphoblastic Leukemia

20 locations incl. Los Angeles

Sponsor: Etan Orgel

Sex: All·Age: 10 - 25

Code: NCT05082519·Phase 2·Recruiting

Apply to this trial

Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy

for Erectile Dysfunction Following Radical Prostatectomy

1 location in Orem

Sponsor: Charitable Union for the Research and Education of Peyronie's Disease

Sex: Male·Age: 18+

Code: NCT05244486·Recruiting

Apply to this trial

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

for Chronic Lymphocytic Leukemia

Drug: Mosunetuzumab

5 locations incl. Rochester

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT05091424·Phase 1·Recruiting

Apply to this trial

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

for COVID-19

50 locations incl. Phoenix

Sponsor: Pfizer

Sex: All·Age: 0 - 17

Code: NCT05261139·Phase 3·Recruiting

Apply to this trial

Inappropriate Sinus Tachycardia Registry

for Inappropriate Sinus Tachycardia

9 locations incl. Palo Alto

Sponsor: AtriCure, Inc.

Sex: All·Age: All ages

Code: NCT05107635·Recruiting

Apply to this trial

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

for Leukemia, Myeloid, Acute

33 locations incl. Newport Beach

Sponsor: Sumitomo Pharma America, Inc.

Sex: All·Age: 12+

Code: NCT04988555·Phase 1, Phase 2·Recruiting

Apply to this trial

Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children

for Respiratory Syncytial Virus Infections

15 locations incl. Birmingham

Sponsor: University of Alabama at Birmingham

Sex: All·Age: 3 Days - 2

Code: NCT05026749·Phase 3·Recruiting

Apply to this trial

Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers

for Chronic Lymphocytic Leukemia

1 location in Salt Lake City

Sponsor: University of Utah

Sex: All·Age: 18+

Code: NCT04844528·Phase 2·Recruiting

Apply to this trial

Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy

for Cerebral Palsy

4 locations incl. Atlanta

Sponsor: Emory University

Sex: All·Age: 4 Months - 13 Months

Code: NCT04997109·Recruiting

Apply to this trial

TReatment for ImmUne Mediated PathopHysiology

for Acute Liver Failure

24 locations incl. Los Angeles

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All·Age: 1 - 18

Code: NCT04862221·Phase 2·Recruiting

Apply to this trial

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

for Adenocarcinoma of the Colon

472 locations incl. Fairbanks

Sponsor: NRG Oncology

Sex: All·Age: 45 - 70

Code: NCT05080673·Recruiting

Apply to this trial

US Post-Market Surveillance Study of the Surfacer System

for Venous Disease

9 locations incl. Tucson

Sponsor: Merit Medical Systems, Inc.

Sex: All·Age: 18+

Code: NCT05050799·Recruiting

Apply to this trial

A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

for Stereotypical Prolonged Seizures

53 locations incl. Phoenix

Sponsor: UCB Biopharma SRL

Sex: All·Age: 12+

Code: NCT05076617·Phase 3·Enrolling By Invitation

Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial

for Chronic Lymphocytic Leukemia

1 location in Salt Lake City

Sponsor: University of Utah

Sex: All·Age: 18+

Code: NCT05183854·Phase 2·Recruiting

Apply to this trial

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

for Diffuse Midline Glioma, H3 K27-Altered

34 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: 12 Months - 21

Code: NCT04870944·Phase 1, Phase 2·Recruiting

Apply to this trial

Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)

for Migraine

Drug: Ubrogepant

109 locations incl. Huntsville

Sponsor: AbbVie

Sex: All·Age: 6 - 17

Code: NCT05127954·Phase 3·Enrolling By Invitation

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

for Migraine

Drug: Ubrogepant

125 locations incl. Huntsville

Sponsor: AbbVie

Sex: All·Age: 6 - 17

Code: NCT05125302·Phase 3·Recruiting

Apply to this trial

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

for AMD

107 locations incl. Phoenix

Sponsor: AbbVie

Sex: All·Age: 50 - 89

Code: NCT05407636·Phase 3·Recruiting

Apply to this trial

Primary Sclerosing Cholangitis in Children

for Primary Sclerosing Cholangitis

11 locations incl. Los Angeles

Sponsor: Arbor Research Collaborative for Health

Sex: All·Age: 2 - 25

Code: NCT04181138·Recruiting

Apply to this trial

Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone

for Pain, Postoperative

2 locations incl. Redwood City

Sponsor: Stanford University

Sex: All·Age: 45+

Code: NCT04676802·Phase 2·Recruiting

Apply to this trial

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

for Myeloid Leukemia, Philadelphia Positive

8 locations incl. Indianapolis

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 1 - 17

Code: NCT04925479·Phase 1, Phase 2·Recruiting

Apply to this trial

Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior

for Congenital Heart Disease in Children

5 locations incl. San Francisco

Sponsor: University of Utah

Sex: Female·Age: 0 - 52

Code: NCT05767385·Phase 2, Phase 3·Recruiting

Apply to this trial

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

for Solid and Hematological Malignancies

49 locations incl. Gilbert

Sponsor: Kite, A Gilead Company

Sex: All·Age: All ages

Code: NCT05041309·Enrolling By Invitation

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

for Neovascular Age-related Macular Degeneration

Drug: Ranibizumab

51 locations incl. Mesa

Sponsor: Genentech, Inc.

Sex: All·Age: 50+

Code: NCT04853251·Phase 4·Recruiting

Apply to this trial

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

for PIK3CA Mutation

24 locations incl. Tucson

Sponsor: Relay Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT05216432·Phase 1·Recruiting

Apply to this trial

A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

for Stereotypical Prolonged Seizures

66 locations incl. Phoenix

Sponsor: UCB Biopharma SRL

Sex: All·Age: 12+

Code: NCT05077904·Phase 3·Recruiting

Apply to this trial

Sit Less, Interact and Move More (SLIMM) 2 Study

for Chronic Kidney Diseases

2 locations incl. Stanford

Sponsor: Srinvasan Beddhu

Sex: All·Age: 20+

Code: NCT05173714·Phase 2·Recruiting

Apply to this trial

(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

for Indolent Systemic Mastocytosis

14 locations incl. Birmingham

Sponsor: Blueprint Medicines Corporation

Sex: All·Age: 18+

Code: NCT04910685·Phase 2, Phase 3·Recruiting

Apply to this trial

Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

for Chronic Phase Chronic Myelogenous Leukemia

4 locations incl. Detroit

Sponsor: Medical College of Wisconsin

Sex: All·Age: 18+

Code: NCT04838041·Phase 2·Recruiting

Apply to this trial

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

for Advanced Systemic Mastocytosis (AdvSM)

14 locations incl. Birmingham

Sponsor: Cogent Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT04996875·Phase 2·Recruiting

Apply to this trial

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

for Non-Small Cell Lung Cancer

Drug: Bevacizumab

19 locations incl. Duarte

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT05005403·Phase 1·Recruiting

Apply to this trial

Combination Therapy for the Treatment of Diffuse Midline Gliomas

for Diffuse Intrinsic Pontine Glioma

19 locations incl. Birmingham

Sponsor: University of California, San Francisco

Sex: All·Age: 2 - 39

Code: NCT05009992·Phase 2·Recruiting

Apply to this trial

Multi-Center Clinical Database of Infants for the Investigation of Early Nutrition Biomarkers

for Infant Development

9 locations incl. Birmingham

Sponsor: ByHeart

Sex: All·Age: 0 Days - 5

Code: NCT05049655·Enrolling By Invitation

US National OCS Liver Perfusion (OLP) Registry

for Liver Transplant

22 locations incl. Birmingham

Sponsor: TransMedics

Sex: All·Age: All ages

Code: NCT05940857·Recruiting

Apply to this trial

Hypoxia Imaging for Esophageal Cancer to Guide Personalized Radiation Therapy

for Esophageal Cancer

1 location in Salt Lake City

Sponsor: University of Utah

Sex: All·Age: 18+

Code: NCT04846309·Phase 1·Recruiting

Apply to this trial

Shoulder Pacemaker for Scapular Dyskinesia

for Scapular Dyskinesis

1 location in Salt Lake City

Sponsor: University of Utah

Sex: All·Age: 18 - 80

Code: NCT05116722·Enrolling By Invitation

The SINCERE Intervention to Address COVID-19 Health Disparities

for COVID-19

1 location in Salt Lake City

Sponsor: Andrea Wallace

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT05228886·Recruiting

Apply to this trial